Examkin

Soru

Zorluk: OrtaEndocrine and Metabolic Mechanisms

An ambulance brings a 68-year-old male patient to the acute care unit due to altered mental status and hyperventilation that began earlier today. His wife reports that he had a severe gastrointestinal illness over the last three days with profound watery diarrhea, leading to significantly decreased oral fluid intake. His past medical history is significant for hypertension, stable angina, and type 2 diabetes mellitus. He has continued to take his prescribed daily medications despite his recent illness.

Physical examination reveals a lethargic, difficult-to-arouse patient with deep, rapid respirations. Vital signs include a blood pressure of 88/54 mm Hg, heart rate of 115/min, and respiratory rate of 28/min. The abdomen is diffusely tender but soft.

Initial laboratory evaluation shows:
- Sodium: 138 mEq/L
- Potassium: 5.2 mEq/L
- Chloride: 98 mEq/L
- Bicarbonate: 10 mEq/L
- Blood urea nitrogen: 54 mg/dL
- Creatinine: 3.2 mg/dL (baseline was 1.4 mg/dL one month ago)
- Glucose: 145 mg/dL
- Lactate: 9.5 mmol/L (Normal: 0.5 - 2.2 mmol/L)

An arterial blood gas drawn on room air demonstrates a pH of 7.22 and a pCO2 of 24 mm Hg.

The drug most likely responsible for this acute presentation lowers serum glucose primarily through which of the following cellular mechanisms?

  1. Inhibition of mitochondrial glycerophosphate dehydrogenase and complex ICevap
  2. B
    Inhibition of sodium-glucose cotransporter 2 in the proximal renal tubule
  3. C
    Closure of ATP-sensitive potassium channels in the pancreatic beta cell membrane
  4. D
    Activation of the peroxisome proliferator-activated receptor-gamma transcription factor
  5. E
    Agonism of glucagon-like peptide-1 receptors leading to increased intracellular cyclic AMP

Cevap

Inhibition of mitochondrial glycerophosphate dehydrogenase and complex I
The correct answer identifies the cellular mechanism of metformin. This patient is presenting with a classic case of metformin-induced lactic acidosis. He developed an acute kidney injury secondary to volume depletion from severe gastroenteritis. Because metformin is cleared unchanged by the kidneys, acute renal failure leads to drug accumulation. Toxic levels of metformin interfere with mitochondrial respiration by inhibiting mitochondrial glycerophosphate dehydrogenase (mGPD) and complex I of the electron transport chain. This inhibition disrupts the conversion of lactate to pyruvate in the liver, leading to a profound accumulation of lactate and a severe high anion gap metabolic acidosis. Metformin's therapeutic effect of reducing hepatic gluconeogenesis also stems from this pathway, as the resulting increased intracellular AMP levels activate AMP-activated protein kinase (AMPK).

Adım Adım Çözüm

1
Analyze the acid-base and electrolyte values to determine the primary metabolic derangement.
The patient has a severe high anion gap metabolic acidosis (pH 7.22, bicarbonate 10 mEq/L, anion gap = 138 - (98 + 10) = 30 mEq/L) with appropriate respiratory compensation.
Categorizing the metabolic state is essential to narrowing the differential diagnosis for the patient's altered mental status and hyperventilation.
2
Identify the specific cause of the high anion gap metabolic acidosis using the provided laboratory data.
The remarkably elevated serum lactate level (9.5 mmol/L) definitively identifies lactic acidosis as the cause of the high anion gap.
Different etiologies of high anion gap metabolic acidosis (e.g., ketoacidosis, uremia, toxic alcohols, lactic acidosis) require distinct management strategies.
3
Connect the etiology of the lactic acidosis to the patient's clinical history and medication use.
The patient has an acute kidney injury (creatinine 3.2 mg/dL) from severe volume depletion. In a patient taking medications for type 2 diabetes, this acute renal failure triggers the accumulation of renally-cleared metformin, leading to metformin-induced lactic acidosis.
Establishing the pharmacological trigger is necessary to answer the prompt regarding the offending drug.
4
Identify the cellular mechanism of action for the offending drug (metformin).
Metformin primarily lowers blood glucose by inhibiting mitochondrial glycerophosphate dehydrogenase (mGPD) and complex I of the electron transport chain.
The stem explicitly asks for the underlying molecular pathway of the responsible medication.

Anahtar Kavram

Metformin reduces hepatic gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase and complex I; it can cause severe, life-threatening lactic acidosis when it accumulates in the setting of acute kidney injury.
Bu soruyu puanla

Konular

Endocrine and Metabolic Mechanisms

Bu konudan daha fazla soru